down arrow

Genky DrugStores Co., Ltd.

  • Market Cap: Small Cap
  • Industry: Retailing
  • ISIN: JP3282750003
  • TKS: 9267
JPY
3,475.00
-20 (-0.57%)

Sep 25

TKS

 View all stocks in this country
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationQuarterly Results
Results Snapshot
YoYQoQ
Figures in Million
Consolidate Quarterly Results
Jun'26
Mar'26
Dec'25
Sep'25
Jun'25
Mar'25
Dec'24
Net Sales
58,928.00
52,449.00
53,219.00
56,042.00
53,403.00
48,625.00
48,708.00
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
58,928.00
52,449.00
53,219.00
56,042.00
53,403.00
48,625.00
48,708.00
Raw Material Cost
46,818.00
41,914.00
42,289.00
44,694.00
42,288.00
38,759.00
38,903.00
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
104.00
81.00
66.00
62.00
64.00
44.00
34.00
Selling and Distribution Expenses
9,148.00
8,231.00
8,128.00
8,431.00
8,297.00
7,622.00
7,482.00
Other Expenses
-10.40
-8.10
-6.60
-6.20
-6.40
-4.40
-3.40
Total Expenditure (Excl Depreciation)
55,966.00
50,145.00
50,417.00
53,125.00
50,585.00
46,381.00
46,385.00
Operating Profit (PBDIT) excl Other Income
2962
2304
2802
2917
2818
2244
2323
Other Income
130.00
98.00
148.00
100.00
103.00
125.00
132.00
Operating Profit (PBDIT)
5,063.00
4,204.00
4,671.00
4,656.00
4,659.00
3,965.00
3,981.00
Interest
104.00
81.00
66.00
62.00
64.00
44.00
34.00
Exceptional Items
2.00
0.00
1.00
1.00
-2.00
0.00
0.00
Gross Profit (PBDT)
12,110.00
10,535.00
10,930.00
11,348.00
11,115.00
9,866.00
9,805.00
Depreciation
1,971.00
1,802.00
1,721.00
1,639.00
1,738.00
1,596.00
1,526.00
Profit Before Tax
2,991.00
2,323.00
2,883.00
2,956.00
2,857.00
2,323.00
2,422.00
Tax
737.00
721.00
900.00
919.00
664.00
718.00
739.00
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
2,254.00
1,601.00
1,983.00
2,037.00
2,193.00
1,605.00
1,684.00
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
2,254.00
1,601.00
1,983.00
2,037.00
2,193.00
1,605.00
1,684.00
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
2,254.00
1,601.00
1,983.00
2,037.00
2,193.00
1,605.00
1,684.00
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
0.0
0.0
0.0
0.0
0.0
0.0
0.0
Reserves
61,373.00
59,090.00
57,644.00
55,299.00
53,428.00
51,213.00
49,793.00
Earnings per share (EPS)
73.72
52.35
64.83
66.79
71.98
52.72
55.28
Diluted Earnings per share
73.72
52.35
64.83
66.79
71.98
52.72
55.28
Operating Profit Margin (Excl OI)
5.03%
4.39%
5.27%
5.21%
5.28%
4.61%
4.77%
Gross Profit Margin
8.42%
7.86%
8.65%
8.2%
8.6%
8.06%
8.11%
PAT Margin
3.83%
3.05%
3.73%
3.63%
4.11%
3.3%
3.46%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Quarterly Analysis Highlights - YoY
stock-summary

Net Sales

YoY Growth in quarter ended Jun 2026 is 10.35% vs 10.63% in Jun 2025

stock-summary

Consolidate Net Profit

YoY Growth in quarter ended Jun 2026 is 2.78% vs 17.40% in Jun 2025

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in quarter ended Jun 2026 is 8.27% vs 13.42% in Jun 2025

stock-summary

Interest

YoY Growth in quarter ended Jun 2026 is 62.50% vs 88.24% in Jun 2025

stock-summary

Operating Profit Margin (Excl OI)

YoY Growth in quarter ended Jun 2026 has fallen from Jun 2025

Compare Quarterly Results Of Genky DrugStores Co., Ltd. With
Markets Mojo
Figures in Million
Consolidate Quarterly Results
Markets Mojo
Markets Mojo
Change(JPY)
Change(%)
Net Sales
58,928.00
1,77,120.00
-1,18,192.00
-66.73%
Other Operating Income
0.00
0.00
0.00
Total Operating income
58,928.00
1,77,120.00
-1,18,192.00
-66.73%
Raw Material Cost
46,818.00
1,54,352.00
-1,07,534.00
-69.67%
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
0.00
0.00
0.00
Power Cost
0
0
0.00
Manufacturing Expenses
104.00
670.00
-566.00
-84.48%
Selling and Distribution Expenses
9,148.00
18,153.00
-9,005.00
-49.61%
Other Expenses
-10.40
-67.00
56.60
84.48%
Total Expenditure (Excl Depreciation)
55,966.00
1,72,505.00
-1,16,539.00
-67.56%
Operating Profit (PBDIT) excl Other Income
2,962.00
4,615.00
-1,653.00
-35.82%
Other Income
130.00
-45.00
175.00
388.89%
Operating Profit (PBDIT)
5,063.00
10,491.00
-5,428.00
-51.74%
Interest
104.00
670.00
-566.00
-84.48%
Exceptional Items
2.00
-632.00
634.00
100.32%
Gross Profit (PBDT)
12,110.00
22,768.00
-10,658.00
-46.81%
Depreciation
1,971.00
5,921.00
-3,950.00
-66.71%
Profit Before Tax
2,991.00
3,269.00
-278.00
-8.50%
Tax
737.00
1,291.00
-554.00
-42.91%
Provisions and contingencies
0
0
0.00
Profit After Tax
2,254.00
1,975.00
279.00
14.13%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
2,254.00
1,975.00
279.00
14.13%
Share in Profit of Associates
0
0
0.00
Minority Interest
0.00
3.00
-3.00
-100.00%
Other related items
0.00
0.00
0.00
Consolidated Net Profit
2,254.00
1,978.00
276.00
13.95%
Equity Capital
0
0
0.00
Face Value
0.00
0.00
0.00
Reserves
61,373.00
1,57,829.00
-96,456.00
-61.11%
Earnings per share (EPS)
73.72
56.16
17.56
31.27%
Diluted Earnings per share
73.72
56.16
17.56
31.27%
Operating Profit Margin (Excl OI)
5.03%
2.61%
0.00
2.42%
Gross Profit Margin
8.42%
5.19%
0.00
3.23%
PAT Margin
3.83%
1.12%
0.00
2.71%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Quarterly - Net Sales
Net Sales 5,892.80 Million
in Jun 2026

Figures in Million
stock-summary

QoQ Growth in quarter ended Jun 2026 is 12.35% vs -1.45% in Mar 2026

stock-summary

YoY Growth in quarter ended Jun 2026 is 10.35% vs 10.63% in Jun 2025

Quarterly - Consolidate Net Profit
Consolidate Net Profit 225.40 Million
in Jun 2026

Figures in Million
stock-summary

QoQ Growth in quarter ended Jun 2026 is 40.79% vs -19.26% in Mar 2026

stock-summary

YoY Growth in quarter ended Jun 2026 is 2.78% vs 17.40% in Jun 2025

Quarterly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 493.30 Million
in Jun 2026

Figures in Million
stock-summary

QoQ Growth in quarter ended Jun 2026 is 20.14% vs -9.22% in Mar 2026

stock-summary

YoY Growth in quarter ended Jun 2026 is 8.27% vs 13.42% in Jun 2025

Quarterly - Interest
Interest 10.40 Million
in Jun 2026

Figures in Million
stock-summary

QoQ Growth in quarter ended Jun 2026 is 28.40% vs 22.73% in Mar 2026

stock-summary

YoY Growth in quarter ended Jun 2026 is 62.50% vs 88.24% in Jun 2025

Quarterly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 5.03%
in Jun 2026

Figures in %
stock-summary

QoQ Growth in quarter ended Jun 2026 has improved from Mar 2026

stock-summary

YoY Growth in quarter ended Jun 2026 has fallen from Jun 2025

Footer loading